|
1
|
Brahmer JR, Govindan R, Anders RA, Antonia
SJ, Sagorsky S, Davies MJ, Dubinett SM, Ferris A, Gandhi L, Garon
EB, et al: The society for immunotherapy of cancer consensus
statement on immunotherapy for the treatment of non-small cell lung
cancer (NSCLC). J Immunother Cancer. 6:752018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
He W, Zhang H, Wang Y, Zhou Y, Luo Y, Cui
Y, Jiang N, Jiang W, Wang H, Xu D, et al: CTHRC1 induces non-small
cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9.
BMC Cancer. 18:4002018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen S, Shi F, Zhang W, Zhou Y and Huang
J: miR-744-5p inhibits non-small cell lung cancer proliferation and
invasion by directly targeting PAX2. Technol Cancer Res Treat.
18:15330338198769132019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nicolaou A, Northoff BH, Zhao Z, Kohlmaier
A, Sass K, Rose-John S, Steffens S, Weber C, Teupser D and Holdt
LM: The ADAM17 metalloproteinase maintains arterial elasticity.
Thromb Haemost. 118:210–213. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang J, Hou L, Liang R, Chen X, Zhang R,
Chen W and Zhu J: CircDLST promotes the tumorigenesis and
metastasis of gastric cancer by sponging miR-502-5p and activating
the NRAS/MEK1/ERK1/2 signaling. Mol Cancer. 18:802019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang S, Zeng X, Ding T, Guo L, Li Y, Ou S
and Yuan H: Microarray profile of circular RNAs identifies
hsa_circ_0014130 as a new circular RNA biomarker in non-small cell
lung cancer. Sci Rep. 8:28782018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Y, Hu J, Li L, Cai S, Zhang H, Zhu X,
Guan G and Dong X: Upregulated circular RNA circ_0016760 indicates
unfavorable prognosis in NSCLC and promotes cell progression
through miR-1287/GAGE1 axis. Biochem Biophys Res Commun.
503:2089–2094. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chang Y, Yan W, Sun C, Liu Q, Wang J and
Wang M: miR-145-5p inhibits epithelial-mesenchymal transition via
the JNK signaling pathway by targeting MAP3K1 in non-small cell
lung cancer cells. Oncol Lett. 14:6923–6928. 2017.PubMed/NCBI
|
|
9
|
Zhao T, Qian K and Zhang Y: High
expression of FGF5 is an independent prognostic factor for poor
overall survival and relapse-free survival in lung adenocarcinoma.
J Comput Biol. 27:948–957. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiao MS and Wilusz JE: An improved method
for circular RNA purification using RNase R that efficiently
removes linear RNAs containing G-quadruplexes or structured 3′
ends. Nucleic Acids Res. 47:8755–8769. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen Y, Peng C, Chen J, Chen D, Yang B, He
B, Hu W, Zhang Y, Liu H, Dai L, et al: WTAP facilitates progression
of hepatocellular carcinoma via m6A-HuR-dependent epigenetic
silencing of ETS1. Mol Cancer. 18:1272019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang X, Yan Y, Lei X, Li A, Zhang H, Dai
Z, Li X, Chen W, Lin W, Chen F, et al: Circular RNA alterations are
involved in resistance to avian leukosis virus subgroup-J-induced
tumor formation in chickens. Oncotarget. 8:34961–34970. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi P, Sun J, He B, Song H, Li Z, Kong W,
Wang J, Wang J and Xue H: Profiles of differentially expressed
circRNAs in esophageal and breast cancer. Cancer Manag Res.
10:2207–2221. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Li Y, He H and Wang F: Circular
RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation
through upregulating EZH2 via sponging miR-377/382/498. Gene.
720:1440992019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang H, Wang X, Hu B, Zhang F, Wei H and
Li L: Circular RNA ZFR accelerates non-small cell lung cancer
progression by acting as a miR-101-3p sponge to enhance CUL4B
expression. Artif Cells Nanomed Biotechnol. 47:3410–3416. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen T, Yang Z, Liu C, Wang L, Yang J,
Chen L and Li W: Circ_0078767 suppresses non-small-cell lung cancer
by protecting RASSF1A expression via sponging miR-330-3p. Cell
Prolif. 52:e125482019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gan TQ, Xie ZC, Tang RX, Zhang TT, Li DY,
Li ZY and Chen G: Clinical value of miR-145-5p in NSCLC and
potential molecular mechanism exploration: A retrospective study
based on GEO, qRT-PCR, and TCGA data. Tumour Biol.
39:10104283176916832017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu Q, Shan S, Li Y, Zhu D, Jin W and Ren
T: Long noncoding RNA SNHG1 promotes non-small cell lung cancer
progression by up-regulating MTDH via sponging miR-145-5p. FASEB J.
32:3957–3967. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jin M, Ren J, Luo M, You Z, Fang Y, Han Y,
Li G and Liu H: Long non-coding RNA JPX correlates with poor
prognosis and tumor progression in non-small-cell lung cancer by
interacting with miR-145-5p and CCND2. Carcinogenesis. 41:634–645.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei CM, Zhao XF, Qiu HB, Ming Z, Liu K and
Yan J: The long non-coding RNA PVT1/miR-145-5p/ITGB8 axis regulates
cell proliferation, apoptosis, migration and invasion in non-small
cell lung cancer cells. Neoplasma. 67:802–812. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou Y, Yu Q, Chu Y, Zhu X, Deng J, Liu Q
and Wang Q: Downregulation of fibroblast growth factor 5 inhibits
cell growth and invasion of human nonsmall-cell lung cancer cells.
J Cell Biochem. Dec 5–2018.(Epub ahead of print).doi:
https://doi.org/10.1002/jcb.28107.
|
|
23
|
Han D, Wang M, Yu Z, Yin L, Liu C, Wang J,
Liu Y, Jiang S, Ren Z and Yin J: FGF5 promotes osteosarcoma cells
proliferation via activating MAPK signaling pathway. Cancer Manag
Res. 11:6457–6466. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ghassemi S, Vejdovszky K, Sahin E,
Ratzinger L, Schelch K, Mohr T, Peter-Vörösmarty B, Brankovic J,
Lackner A, Leopoldi A, et al: FGF5 is expressed in melanoma and
enhances malignancy in vitro and in vivo. Oncotarget.
8:87750–87762. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang Y, Wang H and Yang Y: Expression of
fibroblast growth factor 5 (FGF5) and its influence on survival of
breast cancer patients. Med Sci Monit. 24:3524–3530. 2018.
View Article : Google Scholar : PubMed/NCBI
|
